Michael J Fox has made his return to acting after five years, appearing in the newly released trailer for Shrinking season 3 ...

Though he wasn't seen in the film, he voiced the role of Michael J. the Fox in Disney's animated Zootopia 2, which premiered ...

Amy Lindberg spent 26 years in the Navy and she still walked like it—with intention, like her chin had someplace to be. But around 2017, her right foot stopped following orders. Lindberg and her ...

EDITOR’S NOTE: The podcast Chasing Life With Dr. Sanjay Gupta explores the medical science behind some of life’s mysteries big and small. You can listen to episodes here. The “Shaking Palsy.” Those ...

Your daily step count might reveal more than just your fitness progress. In a study of nearly 95,000 adults wearing activity trackers, lower step totals were linked to later Parkinson’s diagnoses.

Parkinson's disease affects more than 1.1 million people in the U.S. Early treatment of obstructive sleep apnea -- a condition that causes breathing to briefly pause -- may decrease the risk of ...

Parkinson’s disease — which causes poor balance and stiff movement — affects an estimated 1 million Americans. That number is expected to rise by 20% in the next few years. While there’s no sure-fire ...

Those with the sleep condition were more likely to develop Parkinson’s disease. But one treatment was found to help. By Caroline Hopkins Legaspi In a study published Monday in JAMA Neurology, ...

Researchers at UC San Francisco have developed a new way to improve walking for patients with Parkinson’s Disease using deep brain stimulation and artificial intelligence. Deep brain stimulation (DBS) ...

In the late 1960s, scientists discovered a miracle drug for Parkinson’s disease — a simple, inexpensive dopamine-replacement pill called levodopa. It transformed the lives of millions of people.

As teenagers, David Toth and his sister grew up working at their dad’s dry-cleaning business in Rochester, N.Y. Decades later both were diagnosed with Parkinson’s disease. Doctors told them it was ...

The U.S. Food and Drug Administration is reviewing a new Parkinson’s disease drug called tavapadon that could give people with the disease more control over their movements. If approved, it would be ...